We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Sedation and Analgesia for Transjugular Liver Biopsy: A Randomized Double Blind Placebo Controlled Trial

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00596414
First Posted: January 17, 2008
Last Update Posted: January 17, 2008
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by:
Erasme University Hospital
  Purpose
Transjugular liver catheterisation allows the measurement of hepatic venous pressure gradient (HVPG) and the sampling of liver tissue but patient's tolerance to the procedure is unknown. The aim of this study was to assess tolerance to transjugular hepatic liver biopsy with or without conscious sedation/analgesia.

Condition Intervention Phase
Cirrhosis Chronic Hepatitis Anxiety Procedure: transjugular liver biopsy Drug: placebo Drug: midazolam Drug: midazolam + pethidine Phase 4

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Single Group Assignment
Masking: Double (Participant, Investigator)
Primary Purpose: Treatment
Official Title: Sedation and Analgesia for Transjugular Liver Biopsy: A Randomized Double Blind Placebo Controlled Trial

Resource links provided by NLM:


Further study details as provided by Erasme University Hospital:

Primary Outcome Measures:
  • Patient tolerance to the procedure [ Time Frame: 1 hour after the procedure ]

Enrollment: 180
Study Start Date: May 2003
Study Completion Date: October 2005
Primary Completion Date: October 2005 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Placebo Comparator: 1 Procedure: transjugular liver biopsy
liver biopsy through the transjugular route with hepatic-venous pressure gradient measurement
Drug: placebo
Experimental: 2
midazolam
Procedure: transjugular liver biopsy
liver biopsy through the transjugular route with hepatic-venous pressure gradient measurement
Drug: midazolam
Experimental: 3
midazolam + pethidine
Procedure: transjugular liver biopsy
liver biopsy through the transjugular route with hepatic-venous pressure gradient measurement
Drug: midazolam + pethidine

Detailed Description:
Consecutive patients undergoing transjugular liver biopsy will be randomly assigned to receive either placebo or midazolam (0.02 mg/kg) or 0.02 mg/kg midazolam combined with 1 mg/kg pethidine before the procedure.
  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years to 80 Years   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • suspected liver disease
  • known liver disease

Exclusion Criteria:

  • liver transplants
  • hepatocellular carcinoma
  • hypersensitivity or allergy to benzodiazepines or morphinic derivatives
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00596414


Locations
Belgium
Hopital Erasme - Dpt of Gastroenterology
Brussels, Belgium, 1070
Sponsors and Collaborators
Erasme University Hospital
  More Information

Responsible Party: Olivier Le Moine, MD, PhD, Erasme University Hospital
ClinicalTrials.gov Identifier: NCT00596414     History of Changes
Other Study ID Numbers: BHTJ-1
First Submitted: January 8, 2008
First Posted: January 17, 2008
Last Update Posted: January 17, 2008
Last Verified: December 2007

Keywords provided by Erasme University Hospital:
liver
biopsy

Additional relevant MeSH terms:
Hepatitis, Chronic
Hepatitis
Liver Diseases
Digestive System Diseases
Liver Extracts
Midazolam
Meperidine
Hematinics
Adjuvants, Anesthesia
Hypnotics and Sedatives
Central Nervous System Depressants
Physiological Effects of Drugs
Anti-Anxiety Agents
Tranquilizing Agents
Psychotropic Drugs
Anesthetics, Intravenous
Anesthetics, General
Anesthetics
GABA Modulators
GABA Agents
Neurotransmitter Agents
Molecular Mechanisms of Pharmacological Action
Analgesics, Opioid
Narcotics
Analgesics
Sensory System Agents
Peripheral Nervous System Agents